JASP-1 | Control group | ||
---|---|---|---|
CHAQ | Mean (SD) (n) (95% CI) | Mean (SD) (n) (95% CI) | P-value |
At diagnosis | 0.68 (0.58) (n = 49) (0.51 − 0.84) | 0.72 (0.82) (n = 12) (0.17 − 1.27) | 0.781 |
At 12 months | 0.15 (0.29) (n = 48) (0.07 − 0.24) | 0.40 (0.54) (n = 19) (0.13 − 0.67) | 0.017** |
Active joints | Mean (SD) (n) (95% CI) | Mean (SD) (n) (95% CI) | P-value |
At diagnosis | 5.64 (6.48) (n = 53) (3.85 − 7.43) | 6.11 (6.48) (n = 19) (2.98 − 9.23) | 0.624 |
At 12 months | 0.62 (3.47) (n = 50) (0.35 − 1.58) | 0.87 (1.6) (n = 23) (0.18 − 1.59) | 0.054* |